Clinical trial
Efficacy and Safety of Different Ticagrelor Regimens Versus Clopidogrel in Patients With Coronary Artery Disease: a Retrospective Multicenter Study (SUPERIOR)
NCT03381742 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Different Ticagrelor Regimens Versus Clopidogrel in Patients With Coronary Artery Disease: a Retrospective Multicenter Study (SUPERIOR)
- Lead sponsor
- First Affiliated Hospital of Harbin Medical University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 13, 2017
- Completion date
- February 13, 2019
- Enrollment
- 3,043 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.